Sendero Wealth Management’s Amgen AMGN Stock Holding History

Sendero Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-618	Closed	-$202K	–	206
2025 Q4	$202K	Buy	+618	New	+$196K	0.02%	195

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Sendero Wealth Management's AMGN Position: Q1 2026 in Review

Sendero Wealth Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 618 shares — an estimated $202K sold.

Sendero Wealth Management first reported a position in AMGN in Q4 2025 and held it in 1 quarter. The position peaked at $202K in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Sendero Wealth Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Sendero Wealth Management sold 618 Amgen shares in Q1 2026, an estimated $202K.
Sendero Wealth Management first reported a position in Amgen in Q4 2025 and held it in 1 quarter.
Sendero Wealth Management's Amgen position peaked at $202K in Q4 2025.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Sendero Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.